ArticleAmerican journal of translational research2021
Failure mode and effects analysis on the control effect of multi-drug-resistant bacteria in ICU patients.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 4 citations in OpenAlex.
- Swine Influenza Virus Introduction in Pig Farms: A Semi-Quantitative Risk Assessment in Northern Italy.Animals : an open access journal from MDPI · 2026Article
- An Integrated FMEA-RCA Risk-Management Approach for Deep Vein Thrombosis Prevention in Patients Undergoing Total Knee Arthroplasty.Risk management and healthcare policy · 2026Article
- Healthcare Application of Failure Mode and Effect Analysis (FMEA): Is There Room in the Infectious Disease Setting? A Scoping Review.Healthcare (Basel, Switzerland) · 2025Article
- Effectiveness of Failure Mode and Effects Analysis in managing skin complications in ICU psychiatric patients: a real-world study.Frontiers in psychiatry · 2025Article
- Application of Failure Mode and Effects Analysis to Improve the Quality of the Front Page of Electronic Medical Records in China: Cross-Sectional Data Mapping Analysis.JMIR medical informatics · 2024Article
- Preventive Risk Assessment of Medication in Intensive Wards.International journal of preventive medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe failure mode and effect analysis of the prevention and control in intensive care unit (ICU) patients with multi-drug-resistant (MDR) bacterial infection were explored and analyzed in this research.
methodsA total of 251 critically ill patients who were hospitalized in the ICU from June to December 2019 were selected as the control group, and another 258 patients who were hospitalized in the ICU from January to June 2020 were set as the observation group. The control-group patients received conventional ICU care, the observation group was treated by the failure mode and effects analysis (FMEA), and then the prevention and control effect of the two nursing modes on multi-drug-resistant bacteria infection in the two groups were compared accordingly.
resultsThe RPN values of the five highest-level factors in the nursing process were critically lower after the improved interventions than before the improvement. The infection rate of MDR bacteria in the observation group was obviously lower than that in the control group (14.73%, 26.69%,
conclusionThrough the application of FMEA to prevent MDR bacterial infection in ICU patients, nursing staff can accurately pay attention to the keynotes in nursing process, and as such reduce the proportion and mortality of MDR infection in ICU patients and promote the patients' satisfaction with nursing, which are all worthy of clinical application.
Indexed as
Identifiers
34650755PMC8507006W3206965965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.